2023
Maternal FGF2 levels associated with child anxiety and depression symptoms through child FGF2 levels
Lebowitz E, Marin C, Orbach M, Salmaso N, Vaccarino F, Silverman W. Maternal FGF2 levels associated with child anxiety and depression symptoms through child FGF2 levels. Journal Of Affective Disorders 2023, 326: 193-197. PMID: 36717031, PMCID: PMC10104478, DOI: 10.1016/j.jad.2023.01.090.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAnxietyAnxiety DisordersChildDepressionFemaleFibroblast Growth Factor 2HumansMother-Child RelationsMothersConceptsFGF2 levelsDepressive symptomsDepression symptomsChild anxietySymptoms of anxietyRatings of anxietyGrowth factor 2Maternal anxietySymptomsDepressed childrenDepressionChild depressionMothersChildrenFactor 2Self-report ratingsAnxietyIntergenerational pathwaysNon-referred childrenRange of anxietyFGF2AssociationLevelsMaternal
2021
Fibroblast Growth Factor 2 Implicated in Childhood Anxiety and Depression Symptoms
Lebowitz ER, Orbach M, Marin CE, Salmaso N, Vaccarino FM, Silverman WK. Fibroblast Growth Factor 2 Implicated in Childhood Anxiety and Depression Symptoms. Journal Of Affective Disorders 2021, 282: 611-616. PMID: 33445083, PMCID: PMC7897422, DOI: 10.1016/j.jad.2020.12.055.Peer-Reviewed Original Research
2018
Fibroblast growth factor 2 is necessary for the antidepressant effects of fluoxetine
Simard S, Shail P, MacGregor J, Sayed M, Duman RS, Vaccarino FM, Salmaso N. Fibroblast growth factor 2 is necessary for the antidepressant effects of fluoxetine. PLOS ONE 2018, 13: e0204980. PMID: 30273396, PMCID: PMC6166983, DOI: 10.1371/journal.pone.0204980.Peer-Reviewed Original ResearchConceptsChronic variable stressSelective serotonin reuptake inhibitorsPost-mortem brainsGlucocorticoid receptorTherapeutic effectMood disordersAnxiety behaviorFgf2 knockout miceAnti-depressant effectsSerotonin reuptake inhibitorsEffects of fluoxetineTreatment of depressionHippocampal glucocorticoid receptorsAnti-depressant medicationWild-type miceEffect of CVSAnti-depressive agentsNovel therapeutic targetFGF2 geneFibroblast growth factor-2HPA changesAstroglial functionAntidepressant effectsAntidepressant medicationAntidepressant treatment